DOCSLIB.ORG

A Photoswitchable GABA Receptor Channel Blocker

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Photoswitchable GABA Receptor Channel Blocker Received: 24 December 2018 Revised: 3 March 2019 Accepted: 3 April 2019 DOI: 10.1111/bph.14689 RESEARCH PAPER BJP A photoswitchable GABA receptor channel blocker Galyna Maleeva1 | Daniel Wutz2 | Karin Rustler2 | Alba Nin‐Hill3 | Carme Rovira3,10 | Elena Petukhova6 | Antoni Bautista‐Barrufet7 | Alexandre Gomila‐Juaneda7 | Petra Scholze8 | Franck Peiretti9 | Mercedes Alfonso‐Prieto4,5 | Burkhard König2 | Pau Gorostiza7,10,11 | Piotr Bregestovski1,6,12 1 INSERM, INS, Institut de Neurosciences des Systèmes, Aix‐Marseille University, Marseille, France 2 Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany 3 Departament de Química Inorgànica i Orgànica (Secció de Química Orgànica) and Institut de Química Teòrica i Computacional (IQTCUB), Universitat de Barcelona, Barcelona, Spain 4 Department of Computational Biomedicine, Institute for Advanced Simulations IAS‐5 and Institute of Neuroscience and Medicine INM‐9, Forschungszentrum Jülich GmbH, Jülich, Germany 5 Cécile and Oskar Vogt Institute for Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany 6 Department of Normal Physiology, Kazan State Medical University, Kazan, Russia 7 Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain 8 Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria 9 INSERM 1263, INRA 1260, C2VN, Aix‐Marseille Université, Marseille, France 10 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain 11 Network Biomedical Research Center in Biomaterials, Bioengineering and Nanomedicine (CIBER‐BBN), Spain 12 Institute of Neurosciences, Kazan State Medical University, Kazan, Russia Correspondence Background and Purpose: Anion‐selective Cys‐loop receptors (GABA and glycine Piotr Bregestovski, INSERM, INS, Institut de Neurosciences des Systèmes, Aix‐Marseille receptors) provide the main inhibitory drive in the CNS. Both types of receptor oper- University, 13005 Marseille, France. ate via chloride‐selective ion channels, though with different kinetics, pharmacologi- Email: piotr.bregestovski@univ‐amu.fr; [email protected] cal profiles, and localization. Disequilibrium in their function leads to a variety of Mercedes Alfonso‐Prieto, Department of disorders, which are often treated with allosteric modulators. The few available GABA Computational Biomedicine, Institute for Advanced Simulations IAS‐5 and Institute of and glycine receptor channel blockers effectively suppress inhibitory currents in Neuroscience and Medicine INM‐9, neurons, but their systemic administration is highly toxic. With the aim of developing Forschungszentrum Jülich GmbH, D‐52425 Jülich, Germany. an efficient light‐controllable modulator of GABA receptors, we constructed Email: [email protected] azobenzene‐nitrazepam (Azo‐NZ1), which is composed of a nitrazepam moiety Pau Gorostiza, Institute for Bioengineering of merged to an azobenzene photoisomerizable group. Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Experimental Approach: The experiments were carried out on cultured cells Spain. ‐ Email: [email protected] expressing Cys loop receptors of known subunit composition and in brain slices using patch‐clamp. Site‐directed mutagenesis and molecular modelling approaches were Funding information ‐ Agència de Gestió d'Ajuts Universitaris i de applied to evaluate the mechanism of action of Azo NZ1. Recerca, Grant/Award Number: 2017‐SGR‐ Abbreviations: Azo‐NZ, azobenzene‐nitrazepam; TM, transmembrane domain; Vh, holding membrane potential -------------------------------------------------------------------------------------------------------------------------------- This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. © 2019 Institut de Neurosciences des Systémes. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. Br J Pharmacol. 2019;176:2661–2677. wileyonlinelibrary.com/journal/bph 2661 2662 BJP MALEEVA ET AL. 1442; Ministerio de Economía y Key Results: At visible light, being in trans‐configuration, Azo‐NZ1 blocked Competitividad, Grant/Award Number: ‐ CTQ2016 80066R; Barcelona Supercomputing heteromeric α1/β2/γ2 GABAA receptors, ρ2 GABAA (GABAC), and α2 glycine recep- Center, Grant/Award Numbers: BCV‐2016‐3‐ tors, whereas switching the compound into cis‐state by UV illumination restored the 0005 and BCV‐2016‐2‐0002; MINECO; Ramón Areces Foundation; Fundaluce Foundation; activity. Azo‐NZ1 successfully photomodulated GABAergic currents recorded from Human Brain Project WAVESCALES; FEDER; dentate gyrus neurons. We demonstrated that in trans‐configuration, Azo‐NZ1 blocks AGAUR/Generalitat de Catalunya, Grant/ Award Number: 2017‐SGR‐1442; Algorish; the Cl‐selective ion pore of GABA receptors interacting mainly with the 2′ level of the Russian Science Foundation, Grant/Award TM2 region. Number: 18‐15‐00313; ERA SynBIO, Grant/ Award Number: PCIN‐2015‐163‐C02‐01 Conclusions and Implications: Azo‐NZ1 is a soluble light‐driven Cl‐channel blocker, which allows photo‐modulation of the activity induced by anion‐selective Cys‐loop receptors. Azo‐NZ1 is able to control GABAergic postsynaptic currents and provides new opportunities to study inhibitory neurotransmission using patterned illumination. 1 | INTRODUCTION What is already known • Pharmacological activity of ligands can be regulated with The major inhibitory neurotransmission in the mammalian CNS is azobenzene photochromic group, which changes its provided by GABAA, GABAA ρ (also known as GABAC ρ receptor; configuration upon illumination with light of different see Alexander et al., 2015), and glycine receptors (Langosch, Becker, wavelength. & Betz, 1990). In different combinations, these receptors are widely expressed throughout the nervous system and are involved in physio- What this study adds logical functions such as cognition, learning, memory, and motor • Azobenzene‐nitrazepam based photochromic compound control. Disequilibrium in the functioning of GABA and glycine (Gly) Azo‐NZ1 is a light controllable channel blocker of receptors leads to important disorders including epilepsy, anxiety, heteromeric GABA , homomeric GABA ρ2 receptors, depression, misbalance of blood pressure, sleep disorders, schizophre- A C and α2 GlyRs. nia, and hyperekplexia (Johnston, Chebib, Hanrahan, & Mewett, 2003; Tan, Rudolph, & Lüscher, 2011; Sieghart, 2015; Lynch, 2004). • Azo‐NZ1 modulates in a light-dependent manner The activity of GABAA receptors can be successfully regulated synaptic GABAergic currents in dentate gyrus of with allosteric modulators like benzodiazepines, including flumazenil hippocampal brain slices. and diazepam. They are among the most popular pharmacological drugs and are commonly prescribed to treat insomnia, anxiety, and What is the clinical significance convulsions. Benzodiazepines can potentiate GABA receptors through • Azo‐NZ1 modulates in a light‐dependent manner interaction with different sites in the receptor displaying nano‐ and synaptic GABAergic currents in dentate gyrus of micromolar affinities (Sieghart, 2015). Therefore, benzodiazepine hippocampal brain slices. derivatives are convenient scaffolds to develop new modulators of GABA receptor function. Light‐switchable ligands have become a useful tool to specifically control ionic channels, cellular functions, the activity of neuronal characterized their properties. Herein, we describe the interaction of circuits, and behaviour (Gorostiza & Isacoff, 2008; Kramer, Mourot, & one of these compounds, azobenzene‐nitrazepam‐1 (Azo‐NZ1), with Adesnik, 2013). The pharmacological activity of ligands can be regulated several subtypes of anion‐selective Cys‐loop receptors (GABAA, with photochromic groups—molecules that change their configuration GABAC and glycine receptors). Azo‐NZ1 successfully photocontrolled upon illumination with different wavelengths. Azobenzene undergoes a GABAergic currents in cultured cells and in brain slices, but in rapid trans–cis photoisomerization and has been widely used for this pur- contrast to the intended design to obtain an allosteric ligand of the pose. In the dark, or under visible light irradiation, azobenzene is in the classical diazepam site, we found that the azobenzene sulfonyl group elongated trans‐configuration, while upon illumination with UV light introduced alters the binding properties of the compound, enabling (360–380 nm), it isomerizes to its cis‐state and becomes shorter by sev- light‐controlled blocking of the chloride‐selective ion pore. Thus, eral angstroms (Gorostiza & Isacoff, 2008; Yu & Ikeda, 2004). Azo‐NZ1 reveals a class of photochromic ligand with a structure capa- With the aim of regulating the activity of GABA receptors with light, ble of blocking the anion‐selective channel pore of several Cys‐loop we constructed a series of azobenzene derivatives of nitrazepam and receptors. 2663 MALEEVA ET AL. BJP 2 | METHODS used for recording mass spectra. UV/Vis absorption spectroscopy was accomplished using a Varian Cary BIO 50 UV/Vis spectrometer in 10‐ 2.1 | Synthesis of compounds mm quartz cuvettes. IR spectra were recorded on an Agilent Cary 630 FT‐IR spectrometer, and the peak positions are reported in wavenumbers
Load more

Recommended publications
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Thesis Rests with Its Author
    University of Bath PHD A modelling study of the ligand-gated ion-channel superfamily of receptors Cockcroft, Victor Barrie Award date: 1992 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 08. Oct. 2021 A MODELLING STUDY OF THE LIGAND-GATED ION-CHANNEL SUPERFAMILY OF RECEPTORS. submitted by Victor Barrie Cockcroft for the degree of Ph.D. at the University of Bath 1992 Copyright Attention is drawn to the fact that the copyright of this thesis rests with its author. This copy of the thesis has been supplied on the condition that anyone who con­ sults it is understood to recognize that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published with­ out the prior written consent of the author.
    [Show full text]
  • Assessment of Molecular Action of Direct Gating and Allosteric Modulatory Effects of Carisoprodol (Somartm) on GABA a Receptors
    Graduate Theses, Dissertations, and Problem Reports 2015 Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors Manoj Kumar Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Kumar, Manoj, "Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors" (2015). Graduate Theses, Dissertations, and Problem Reports. 6022. https://researchrepository.wvu.edu/etd/6022 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. ASSESSMENT OF MOLECULAR ACTION OF DIRECT GATING AND ALLOSTERIC MODULATORY EFFECTS OF MEPROBAMATE (MILTOWN®) ON GABAA RECEPTORS Manish Kumar, MD, MS Dissertation submitted to the School of Pharmacy at West Virginia University in partial fulfillment of Requirements
    [Show full text]
  • Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor
    The Journal of Neuroscience, January 15, 1997, 17(2):625–634 Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor Shinya Ueno,1 John Bracamontes,1 Chuck Zorumski,2 David S. Weiss,3 and Joe Henry Steinbach1 Departments of 1Anesthesiology and 2Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, and 3University of Alabama at Birmingham, Neurobiology Research Center and Department of Physiology and Biophysics, Birmingham, Alabama 35294-0021 Anesthetic drugs are known to interact with GABAA receptors, bicuculline only partially blocked responses to pentobarbital. both to potentiate the effects of low concentrations of GABA and These observations indicate that the blockers do not compete to directly gate open the ion channel in the absence of GABA; with alphaxalone or pentobarbital for a single class of sites on the however, the site(s) involved in direct gating by these drugs is not GABAA receptor. Finally, at receptors containing a1b2(Y157S)g2L known. We have studied the ability of alphaxalone (an anesthetic subunits, both bicuculline and gabazine showed weak agonist steroid) and pentobarbital (an anesthetic barbiturate) to directly activity and actually potentiated responses to alphaxalone. These activate recombinant GABAA receptors containing the a1, b2, and observations indicate that the blocking drugs can produce allo- g2L subunits. Steroid gating was not affected when either of two steric changes in GABAA receptors, at least those containing this mutated b2 subunits [b2(Y157S) and b2(Y205S)] are incorporated mutated b2 subunit. We conclude that the sites for binding ste- into the receptors, although these subunits greatly reduce the roids and barbiturates do not overlap with the GABA-binding site.
    [Show full text]
  • The Effects of the Potential Glycine Receptor Antagonist, Ambd, in Thalamic Ventrobasal Nuclei
    THE EFFECTS OF THE POTENTIAL GLYCINE RECEPTOR ANTAGONIST, AMBD, IN THALAMIC VENTROBASAL NUCLEI by SARAH MONICA MCCARTHY BSc, The University of Windsor, 2004 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE in THE FACULTY OF GRADUATE STUDIES (Pharmacology and Therapeutics) THE UNIVERSITY OF BRITISH COLUMBIA June 2006 © Sarah Monica McCarthy, 2006 ABSTRACT This thesis describes the effects of 6-aminomethyl-3-methyl-4H,l,2,4-benzothiadiazine- 1,1-dioxide (AMBD) on membrane properties and synaptic inhibition in neurons of the ventrobasal (VB) nuclei in the thalamus. Although gamma-aminobutyric acid (GABA) has a well-established role as a neurotransmitter in the VB nuclei, recent evidence demonstrates that this area exhibits glycinergic inhibition that is sensitive to blockade by strychnine. AMBD has pharmacological properties that are consistent with glycine receptor antagonism, but its actions in the thalamus are unknown. The major objective was to determine the effects of AMBD on inhibitory postsynaptic currents (IPSCs) in the VB nuclei evoked by electrical stimulation of the medial lemniscus (ML), the major sensory input. AMBD significantly reduced the peak amplitude of glycinergic and GABAAergic mixed IPSCs, pharmacologically isolated glycinergic and GABAAergic IPSCs, and purely glycinergic IPSCs. AMBD had no effects on most of the purely GABAAergic IPSCs. AMBD eliminated the slow and intermediate, not the fast, decay components of mixed glycinergic and GABAAergic IPSCs. AMBD decreased the apparent frequency but not the amplitude of spontaneous IPSCs (sIPSCs), implicating a possible presynaptic action. We propose that AMBD has both presynaptic and postsynaptic sites of action. According to this proposal, AMBD antagonized the effects of glycine-like amino acids at the postsynaptic fast and slow glycine receptors, as well as at a presynaptic site that attenuates the effects of GABA.
    [Show full text]
  • Pharmacologic Specificity of Nicotinic Receptor-Mediated Relaxation Of
    Supplemental Material can be found at: http://jpet.aspetjournals.org/content/suppl/2011/04/04/jpet.110.177097. DC1.html 0022-3565/11/3381-37–46$25.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 338, No. 1 Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics 177097/3694341 JPET 338:37–46, 2011 Printed in U.S.A. Pharmacologic Specificity of Nicotinic Receptor-Mediated Relaxation of Muscarinic Receptor Precontracted Human Gastric Clasp and Sling Muscle Fibers within the Gastroesophageal Junction□S Alan S. Braverman, Anil K. Vegesna, Larry S. Miller, Mary F. Barbe, Mansoor Tiwana, Kashif Hussain, and Michael R. Ruggieri, Sr. Departments of Urology (A.S.B., M.R.R.), Anatomy and Cell Biology (M.F.B.), and Pharmacology (M.R.R.) and Department of Medicine, Section of Gastroenterology (A.K.V., L.S.M., M.T., K.H.), Temple University School of Medicine, Philadelphia, Downloaded from Pennsylvania Received November 8, 2010; accepted March 31, 2011 ABSTRACT jpet.aspetjournals.org Relaxation of gastric clasp and sling muscle fibers is involved pranolol inhibited, and ginkgolide B was ineffective in both. the transient lower esophageal sphincter relaxations under- SR95531 was ineffective in clasp fibers and partially effective lying the pathophysiology of gastroesophageal reflux dis- in sling fibers. Strychnine and bicuculline prevented relax- ease (GERD). These fibers do not contribute tone to the ations with low potency, indicating actions not on glycine or high-pressure zone in GERD patients, indicating their role in GABAA receptors but more consistent with nicotinic receptor pathophysiology. This study identifies some mediators of the blockade.
    [Show full text]
  • Benzodiazepines and the GABA, Receptor: Effecs of C~~UB~Cexposure
    The University of Alberta Benzodiazepines and the GABA, Receptor: Effecs of C~~UB~CExposure Michelle Ingird Arnot O A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillrnent of the requirements for the degree of Doctor of Philosophy. Department of Pharmacology Edmonton, Alberta FaIl, 1998 National Library Bibliothèque nationale of Canada du Canada Acquisitions and Acquisitions et Bibliographie Services services bibliographiques 395 Wellington Street 395, me Wellington OüawaON K1AW ûüawaON K1AON4 Canada canada The author has granted a non- L'auteur a accorde une licence non exclusive licence allowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sell reproduire, prêter, distn'buer ou copies of this thesis in microform, vendre des copies de cette thése sous paper or electronic formats. la forme de microfiche/nlm, de reproduction sur papier ou sur format élecîronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la thése ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. A mind once stretched by a new idea, never regains its original dimensions. - Author Unknown ABSTRACT The benzodiazepine pharmacological profile includes sedation. anxiolysis. muscle relaxation and anticonvulsant effects; however. after long term treatment with full agonists tolerancc develops to certain aspects of this profile. These cornpounds produce their overt effects via allosrenc modulation of the GABA, receptor.
    [Show full text]
  • World of Cognitive Enhancers
    ORIGINAL RESEARCH published: 11 September 2020 doi: 10.3389/fpsyt.2020.546796 The Psychonauts’ World of Cognitive Enhancers Flavia Napoletano 1,2, Fabrizio Schifano 2*, John Martin Corkery 2, Amira Guirguis 2,3, Davide Arillotta 2,4, Caroline Zangani 2,5 and Alessandro Vento 6,7,8 1 Department of Mental Health, Homerton University Hospital, East London Foundation Trust, London, United Kingdom, 2 Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3 Swansea University Medical School, Institute of Life Sciences 2, Swansea University, Swansea, United Kingdom, 4 Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy, 5 Department of Health Sciences, University of Milan, Milan, Italy, 6 Department of Mental Health, Addictions’ Observatory (ODDPSS), Rome, Italy, 7 Department of Mental Health, Guglielmo Marconi” University, Rome, Italy, 8 Department of Mental Health, ASL Roma 2, Rome, Italy Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. While treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have significant benefits for patients, the increasing recreational use of these substances by healthy individuals raises many clinical, medico-legal, and ethical issues. Moreover, it has become very challenging for clinicians to Edited by: keep up-to-date with CEs currently available as comprehensive official lists do not exist. Simona Pichini, Methods: Using a web crawler (NPSfinder®), the present study aimed at assessing National Institute of Health (ISS), Italy Reviewed by: psychonaut fora/platforms to better understand the online situation regarding CEs.
    [Show full text]
  • Allosteric Activation Mechanism of the A1b2 2 -Aminobutyric Acid Type A
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 2542 Biophysical Journal Volume 77 November 1999 2542–2551 Allosteric Activation Mechanism of the ␣1␤2␥2 ␥-Aminobutyric Acid Type A Receptor Revealed by Mutation of the Conserved M2 Leucine Yongchang Chang and David S. Weiss Departments of Neurobiology and Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0021 USA ABSTRACT A conserved leucine residue in the midpoint of the second transmembrane domain (M2) of the ligand-activated ion channel family has been proposed to play an important role in receptor activation. In this study, we assessed the importance of this leucine in the activation of rat ␣1␤2␥2 GABA receptors expressed in Xenopus laevis oocytes by site-directed mutagenesis and two-electrode voltage clamp. The hydrophobic conserved M2 leucines in ␣1(L263), ␤2(L259), and ␥2(L274) subunits were mutated to the hydrophilic amino acid residue serine and coexpressed in all possible combina- tions with their wild-type and/or mutant counterparts. The mutation in any one subunit decreased the EC50 and created spontaneous openings that were blocked by picrotoxin and, surprisingly, by the competitive antagonist bicuculline. The magnitudes of the shifts in GABA EC50 and picrotoxin IC50 as well as the degree of spontaneous openings were all correlated with the number of subunits carrying the leucine mutation. Simultaneous mutation of the GABA binding site (␤2Y157S; ␤ increased the EC50) and the conserved M2 leucine ( 2L259S; decreased the EC50) produced receptors with the predicted intermediate agonist sensitivity, indicating the two mutations affect binding and gating independently.
    [Show full text]
  • Sternum. ^Sympathetic Chain \ to Prevertebral
    Durham E-Theses An electrophysiological study of the interaction between fenamate NSAIDs and the GABA(_A) receptor Patten, Debra How to cite: Patten, Debra (1999) An electrophysiological study of the interaction between fenamate NSAIDs and the GABA(_A) receptor, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/4561/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 An electrophysiological study of the interaction between Fenamate NSAIDs and the GABAA receptor. Debra Patten Submitted for the Degree of Ph.D. The copyright of this thesis rests with the author. No quotation from it should be published without the written consent of the author and information derived from it should be acknowledged. 1 9 JUL 2000 Dept. of Biological Sciences University of Durham March 1999 March 1999 Table of Contents AN ELECTROPHYSIOLOGICAL STUDY OF THE INTERACTION BETWEEN FENAMATE NSAIDs AND THE GABAA RECEPTOR CHAPTER ONE: GENERAL INTRODUCTION 1.1.
    [Show full text]
  • Gene Expression Changes in Glutamate and GABA-A Receptors
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Alcohol Manuscript Author Clin Exp Res. Author Manuscript Author manuscript; available in PMC 2017 May 01. Published in final edited form as: Alcohol Clin Exp Res. 2016 May ; 40(5): 955–968. doi:10.1111/acer.13056. Gene expression changes in glutamate and GABA-A receptors, neuropeptides, ion channels and cholesterol synthesis in the periaqueductal gray following binge-like alcohol drinking by adolescent alcohol-preferring (P) rats Jeanette N. McClinticka,b, William J. McBridec, Richard L. Bellc, Zheng-Ming Dingc, Yunlong Liud, Xiaoling Xueia,b, and Howard J. Edenberga,b,d,* aDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, United States bCenter for Medical Genomics, Indiana University School of Medicine, Indianapolis, IN 46202, United States cInstitute of Psychiatric Research, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, United States dDepartment of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, United States Abstract Background—Binge-drinking of alcohol during adolescence is a serious public health concern with long-term consequences, including increased pain, fear and anxiety. The periaqueductal gray (PAG) is involved in processing pain, fear and anxiety. The effects of adolescent binge drinking on gene expression in this region have yet to be studied. Methods—Male adolescent P (alcohol preferring) rats were exposed to repeated binge-drinking (three 1-h sessions/day during the dark-cycle, 5 days/week for 3 weeks starting at 28 days of age; ethanol intakes of 2.5 – 3 g/kg/session). We used RNA sequencing to assess the effects of ethanol intake on gene expression.
    [Show full text]
  • GABA Receptors
    Tocris Scientific ReviewReview SeriesSeries Tocri-lu-2945 GABA Receptors Ian L. Martin, Norman G. Bowery Historical Perspective and Susan M.J. Dunn GABA is the major inhibitory amino acid transmitter of the Ian Martin is Professor of Pharmacology in the School of Life and mammalian central nervous system (CNS). Essentially all neurons Health Sciences, Aston University, Birmingham, UK. Norman in the brain respond to GABA and perhaps 20% use it as their 1 Bowery is Emeritus Professor of Pharmacology, University of primary transmitter. Early electrophysiological studies, carried Birmingham, UK. Susan Dunn is Professor and Chair at the out using iontophoretic application of GABA to CNS neuronal Department of Pharmacology, Faculty of Medicine and Dentistry, preparations, showed it to produce inhibitory hyperpolarizing 2 University of Alberta, Canada. All three authors share common responses that were blocked competitively by the alkaloid 3 interests in GABAergic transmission. E-mail: sdunn@pmcol. bicuculline. However, in the late 1970s, Bowery and his ualberta.ca colleagues, who were attempting to identify GABA receptors on peripheral nerve terminals, noted that GABA application reduced the evoked release of noradrenalin in the rat heart and that this Contents effect was not blocked by bicuculline. This action of GABA was Introduction ............................................................................................. 1 mimicked, however, by baclofen (Figure 1), a compound that was unable to produce rapid hyperpolarizing responses
    [Show full text]